Solidus

Solidus Biosciences is a biotechnology company specializing in high-throughput toxicity screening and drug metabolism studies using proprietary 3D cell culture technology. The company's core platforms, the Sol-Chip and Data-Chip, enable the creation of microscale human organ models, such as the liver, to predict drug-induced toxicities more accurately than traditional 2D cultures. By integrating metabolizing enzymes and human cells on a microarray format, Solidus provides a physiologically relevant environment for assessing lead compounds early in the drug discovery process. Their services and products aim to reduce the high costs and ethical concerns associated with animal testing while improving the success rate of clinical trials. The company primarily serves the pharmaceutical, biotechnology, and cosmetic industries through contract research and technology licensing.